Equity alert: rosen law firm encourages y-mabs therapeutics, inc. investors to secure counsel before important deadline in securities class action – ymab

New york--( business wire )--why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of y-mabs therapeutics, inc. (nasdaq: ymab) between october 6, 2020 and october 28, 2022, both dates inclusive (the “class period”). a class action has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than march 20, 2023.
YMAB Ratings Summary
YMAB Quant Ranking